222 related articles for article (PubMed ID: 15827331)
1. Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways.
Ikezoe T; Yang Y; Bandobashi K; Saito T; Takemoto S; Machida H; Togitani K; Koeffler HP; Taguchi H
Mol Cancer Ther; 2005 Apr; 4(4):578-86. PubMed ID: 15827331
[TBL] [Abstract][Full Text] [Related]
2. Eriocalyxin B induces apoptosis in lymphoma cells through multiple cellular signaling pathways.
Zhang YW; Jiang XX; Chen QS; Shi WY; Wang L; Sun HD; Shen ZX; Chen Z; Chen SJ; Zhao WL
Exp Hematol; 2010 Mar; 38(3):191-201. PubMed ID: 20045442
[TBL] [Abstract][Full Text] [Related]
3. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z
Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811
[TBL] [Abstract][Full Text] [Related]
4. Anti-proliferative effects of oridonin on SPC-A-1 cells and its mechanism of action.
Liu JJ; Huang RW; Lin DJ; Peng J; Wu XY; Pan XL; Li MQ; Lin Q
J Int Med Res; 2004; 32(6):617-25. PubMed ID: 15587755
[TBL] [Abstract][Full Text] [Related]
5. Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens.
Hsieh TC; Wijeratne EK; Liang JY; Gunatilaka AL; Wu JM
Biochem Biophys Res Commun; 2005 Nov; 337(1):224-31. PubMed ID: 16176802
[TBL] [Abstract][Full Text] [Related]
6. Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells.
Wang S; Zhong Z; Wan J; Tan W; Wu G; Chen M; Wang Y
Am J Chin Med; 2013; 41(1):177-96. PubMed ID: 23336515
[TBL] [Abstract][Full Text] [Related]
7. Oridonin induces a caspase-independent but mitochondria- and MAPK-dependent cell death in the murine fibrosarcoma cell line L929.
Zhang CL; Wu LJ; Tashiro S; Onodera S; Ikejima T
Biol Pharm Bull; 2004 Oct; 27(10):1527-31. PubMed ID: 15467189
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferation effects of oridonin on HPB-ALL cells and its mechanisms of action.
Liu JJ; Huang RW; Lin DJ; Wu XY; Peng J; Pan XL; Lin Q; Hou M; Zhang MH; Chen F
Am J Hematol; 2006 Feb; 81(2):86-94. PubMed ID: 16432862
[TBL] [Abstract][Full Text] [Related]
9. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors.
Wang YY; Lv YF; Lu L; Cai L
Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795
[TBL] [Abstract][Full Text] [Related]
10. Oridonin stabilizes retinoic acid receptor alpha through ROS-activated NF-κB signaling.
Cao Y; Wei W; Zhang N; Yu Q; Xu WB; Yu WJ; Chen GQ; Wu YL; Yan H
BMC Cancer; 2015 Apr; 15():248. PubMed ID: 25886043
[TBL] [Abstract][Full Text] [Related]
11. Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells.
Ikezoe T; Chen SS; Tong XJ; Heber D; Taguchi H; Koeffler HP
Int J Oncol; 2003 Oct; 23(4):1187-93. PubMed ID: 12964003
[TBL] [Abstract][Full Text] [Related]
12. Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway.
Lu Y; Sun Y; Zhu J; Yu L; Jiang X; Zhang J; Dong X; Ma B; Zhang Q
Cell Death Dis; 2018 Jan; 9(1):15. PubMed ID: 29323103
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic effect of oridonin on NB4 cells and its mechanism.
Liu J; Huang R; Lin D; Wu X; Peng J; Lin Q; Pan X; Zhang M; Hou M; Chen F
Leuk Lymphoma; 2005 Apr; 46(4):593-7. PubMed ID: 16019488
[TBL] [Abstract][Full Text] [Related]
14. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.
Jiang JH; Pi J; Jin H; Cai JY
J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997
[TBL] [Abstract][Full Text] [Related]
15. Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma
Song M; Liu X; Liu K; Zhao R; Huang H; Shi Y; Zhang M; Zhou S; Xie H; Chen H; Li Y; Zheng Y; Wu Q; Liu F; Li E; Bode AM; Dong Z; Lee MH
Mol Cancer Ther; 2018 Jul; 17(7):1540-1553. PubMed ID: 29695636
[TBL] [Abstract][Full Text] [Related]
16. Oridonin induced A375-S2 cell apoptosis via bax-regulated caspase pathway activation, dependent on the cytochrome c/caspase-9 apoptosome.
Zhang CL; Wu LJ; Tashiro S; Onodera S; Ikejima T
J Asian Nat Prod Res; 2004 Jun; 6(2):127-38. PubMed ID: 15008459
[TBL] [Abstract][Full Text] [Related]
17. A novel combination of oridonin and valproic acid in enhancement of apoptosis induction of HL-60 leukemia cells.
Shi M; Ren X; Wang X; Wang H; Liu G; Yuan X; Zheng S; Yu L; Pan S; Song G; Guo Q; Li L; Zhang X; Zhang Z; Ding H; Jiang G
Int J Oncol; 2016 Feb; 48(2):734-46. PubMed ID: 26676928
[TBL] [Abstract][Full Text] [Related]
18. Oridonin-induced apoptosis in leukemia K562 cells and its mechanism.
Liu JJ; Huang RW; Lin DJ; Wu XY; Peng J; Pan XL; Song YQ; Lin Q; Hou M; Wang DN; Chen F; Zhang MH
Neoplasma; 2005; 52(3):225-30. PubMed ID: 15875084
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
Dong X; Liu F; Li M
Anticancer Drugs; 2016 Apr; 27(4):286-99. PubMed ID: 26704389
[TBL] [Abstract][Full Text] [Related]
20. Oridonin Could Inhibit Inflammation and T-cell Immunoglobulin and Mucin-3/Galectin-9 (TIM-3/Gal-9) Autocrine Loop in the Acute Myeloid Leukemia Cell Line (U937) as Compared to Doxorubicin.
Nasri F; Sadeghi F; Behranvand N; Samei A; Bolouri MR; Azari T; Abdollahi E; Ghazizadeh F; Motevalian M; Hassan ZM; Falak R
Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):602-611. PubMed ID: 33463129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
